AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Stroke Risk Should Determine Anti-Clotting Treatment for People With Irregular Heartbeat
Revised ACC/AHA/ESC Guidelines on Atrial Fibrillation Recommend New Approach
DALLAS, Aug. 2 /PRNewswire/ -- Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation released today by the American College of Cardiology, American Heart Association and the European Society of Cardiology.
Atrial fibrillation (AF) is the most common heart rhythm disturbance and it increases the risk for stroke, heart failure and all-cause death, especially in women. Presently AF affects more than 2 million Americans and 4.5 million Europeans, according to the joint statement. The number of patients with atrial fibrillation is expected to increase even more due to an aging population, a rising number of people with chronic heart disease and improved diagnostic possibilities.
During AF, the heart's two upper chambers (the atria) quiver instead of beating effectively. Blood isn't pumped completely out of them, so it may pool and clot. If a piece of a blood clot in the atria leaves the heart and lodges in an artery…
Source: HighBeam Research, American College of Cardiology/American Heart Association/European...